Navigation Links
Axial Biotech Wins 2010 Best New Spinal Technology Award
Date:10/5/2010

SALT LAKE CITY, Oct. 5 /PRNewswire/ -- Axial Biotech, Inc., a company revolutionizing spine care through the development of molecular diagnostic technologies, was selected as a winner at the 2010 Spine Technology Awards. Sponsored by Orthopedics This Week, the largest weekly publication in the spine industry, the 2010 Spine Technology Awards received submissions from hundreds of outstanding technologies. Robin Young, the Publisher of Orthopedics This Week, presented the award to Axial Biotech during an awards ceremony held last night, in advance of the North American Spine Society Meeting in Orlando, Florida

Axial Biotech's award winning product, ScoliScore™AIS Prognostic Test, won in the diagnostics category. The ScoliScore test is the first-ever genetic test for patients diagnosed with Adolescent Idiopathic Scoliosis (AIS). This new molecular diagnostic tool marks a major advancement in which medical treatments can be personalized to patients diagnosed with this deforming disease.

ScoliScore™ was developed by utilizing a genome wide association study that identified a panel of genetic markers associated with severe curve progression. The scoliosis research used in the development of this test included collecting DNA samples from over 10,000 patients from over 100 IRB approved clinical sites throughout the world. The test was then further validated in three separate clinical trials.

The Spine Technology Awards were judged according to their likelihood to advance the care of spine care and treatment using innovative and new technologies. The 30-surgeon panel of judges was selected for their clinical experience and independence -- none were affiliated with the winning technologies. Since treating spinal disorders is one of the most complex medical problems, new technologies have historically played a significant role in advancing the cause of patient care.

Speaking at the awards gala, Orthopedics This Week Publisher Robin Young said, "The spine industry relies on the inspiration and perspiration of researchers, engineers and surgeon-inventors to improve outcomes and control costs. Most of these innovators are little known, so we are proud to provide these awards and a venue to recognize their great talents and contributions."

John Climaco, Axial Biotech's President and CEO accepted the award on behalf of the company. "We are honored to have won the 2010 Spine Technology Award for diagnostics," said Mr. Climaco.  "I am pleased that the distinguished panel of surgeon experts, recognized the unique value of ScoliScore™. Winning the Spinal Technology Award represents tremendous validation for all of the hard work of Axial's employees and all of the surgeons and their staff who participated in the development of this beneficial new technology."

For more information on the ScoliScore™ test, please contact Axial Biotech's Customer Service at 877-AXIAL98 (877-294-2598) or visit the company's website at www.axialbiotech.com

About Axial Biotech  

Axial Biotech, Inc. is the leading developer of molecular diagnostics for common spinal diseases and disorders. Axial markets the SCOLISCORE™ AIS Prognostic Test, the first and only test that utilizes the genetic blueprint of progressive scoliosis to enable physicians to identify which patients are likely to progress to a severe curvature. Axial is accredited by the College of American Pathologists (CAP) and is certified to comply with the Clinical Laboratory Improvement Amendments (CLIA). Axial is a privately held, venture-backed molecular diagnostics company founded in 2002 by a group of internationally recognized spine surgeons and geneticists. The company is based in Salt Lake City, Utah.


'/>"/>
SOURCE Axial Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reimbursement Difficulties With TranS1s AxiaLIF and NuVasives XLIF Have Sceptics Talking
2. Researchers at Axial Biotech Develop a DNA Test for Scoliosis
3. First of many Neuro-Biotechs licensed products, "SymPath(R) blood test"
4. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
5. Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum
6. FierceBiotech Names VentiRx Pharmaceuticals as One of the Fierce 15 Biotech Companies of 2010
7. FierceBiotech Names Obesity Company Gelesis to Fierce 15 List of Top Emerging Biotech Companies
8. Amira Pharmaceuticals Named One of Most Promising Biotech Companies by FierceBiotechs Annual Fierce 15
9. FierceBiotech Designates Alder Biopharmaceuticals One of Top Private Biotechs, Member of the 2010 Fierce 15
10. Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform
11. Pevion Biotech Appoints New CEO and Secures CHF 10 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
(Date:8/7/2017)... , Aug. 7, 2017 Zimmer Biomet Holdings, ... healthcare, today announced that its Board of Directors has approved ... the third quarter of 2017. ... paid on or about October 27, 2017 to stockholders of ... 2017.  Future declarations of dividends are subject to approval of ...
Breaking Medicine Technology:
(Date:8/18/2017)... York, New York (PRWEB) , ... ... ... International Courier, LLC, d/b/a Quick International, LLC (“Quick”), a highly specialized asset-light ... announced it has entered into a definitive agreement to purchase Unitrans International ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry ... educational webinar, they will present the line of epMotion automated liquid handling system. ... you can automate everyday pipetting tasks. , Ideal for scientists and lab technicians ...
(Date:8/18/2017)... ... August 18, 2017 , ... Moore Insurance, a Houston area ... Texas, is launching a regional charity effort to provide publicity assistance and generate ... Brain Tumor Foundation (PBTF) has raised nearly $30 million in donations that has ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... Boca Raton (PRWEB) , ... August 18, 2017 , ... ... is continuing to ramp up its marketing efforts with its product now available through ... hangover remedy to the public. The effervescent powdered drink is designed to quickly detox ...
Breaking Medicine News(10 mins):